IL-6-mediated tumorigenicity and antioxidant state in squamous cell carcinoma cells are driven by CD109 via stabilization of IL-6 receptor-alpha and activation of STAT3/NRF2 pathway

Amani Hassan(McGill University Health Centre), Anie Philip(McGill University Health Centre)
Experimental Hematology and Oncology
May 2, 2025
Cited by 2


Related Papers